{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:11:27Z","timestamp":1791990687080,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02804-7","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:57:04Z","timestamp":1749887824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of different hypertensive disorders of pregnancy on cardiovascular disease risk and all-cause mortality in women with type 1 diabetes"],"prefix":"10.1186","volume":"24","author":[{"given":"Kaarina","family":"Rimpel\u00e4inen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Jansson Sigfrids","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miira M.","family":"Klemetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valma","family":"Harjutsalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Thorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the FinnDiane Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"2804_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107833","volume":"35","author":"X Cai","year":"2021","unstructured":"Cai X, Li J, Cai W, Chen C, Ma J, Xie Z, et al. Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease. J Diabetes Complicat. 2021;35: 107833.","journal-title":"J Diabetes Complicat"},{"key":"2804_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12933-023-01974-6","volume":"22","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang H, Yang Z, Lu Y, Zou C. Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study. Cardiovasc Diabetol. 2023;22:236.","journal-title":"Cardiovasc Diabetol"},{"key":"2804_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00125-015-3787-1","volume":"59","author":"MM Klemetti","year":"2016","unstructured":"Klemetti MM, Laivuori H, Tikkanen M, Nuutila M, Hiilesmaa V, Teramo K. White\u2019s classification and pregnancy outcome in women with type 1 diabetes: a population-based cohort study. Diabetologia. 2016;59:92\u2013100.","journal-title":"Diabetologia"},{"key":"2804_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00125-014-3488-1","volume":"58","author":"MM Klemetti","year":"2015","unstructured":"Klemetti MM, Laivuori H, Tikkanen M, Nuutila M, Hiilesmaa V, Teramo K. Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988\u20132011. Diabetologia. 2015;58:678\u201386.","journal-title":"Diabetologia"},{"key":"2804_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S2213-8587(23)00116-X","volume":"11","author":"K Benhalima","year":"2023","unstructured":"Benhalima K, Beunen K, Siegelaar SE, Painter R, Murphy HR, Feig DS, et al. Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. Lancet Diabetes Endocrinol. 2023;11:490\u2013508.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2804_CR6","doi-asserted-by":"publisher","unstructured":"Bartsch E, Medcalf KE, Park AL, Ray JG; High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. https:\/\/doi.org\/10.1136\/bmj.i1753","DOI":"10.1136\/bmj.i1753"},{"key":"2804_CR7","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1001\/jama.2019.4981","volume":"321","author":"A-S Alexopoulos","year":"2019","unstructured":"Alexopoulos A-S, Blair R, Peters AL. Management of preexisting diabetes in pregnancy: a review. JAMA. 2019;321:1811\u20139.","journal-title":"JAMA"},{"key":"2804_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00592-017-1053-3","volume":"54","author":"P Gutaj","year":"2017","unstructured":"Gutaj P, Zawiejska A, Mantaj U, Wender-O\u017cegowska E. Determinants of preeclampsia in women with type 1 diabetes. Acta Diabetol. 2017;54:1115\u201321.","journal-title":"Acta Diabetol"},{"key":"2804_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCRESAHA.121.319895","volume":"130","author":"AC O\u2019Kelly","year":"2022","unstructured":"O\u2019Kelly AC, Michos ED, Shufelt CL, Vermunt JV, Minissian MB, Quesada O, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022;130:652\u201372.","journal-title":"Circ Res"},{"key":"2804_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccl.2020.09.005","volume":"39","author":"AM Khedagi","year":"2021","unstructured":"Khedagi AM, Bello NA. Hypertensive disorders of pregnancy. Cardiol Clin. 2021;39:77\u201390.","journal-title":"Cardiol Clin"},{"key":"2804_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.ackd.2013.01.014","volume":"20","author":"AG Kattah","year":"2013","unstructured":"Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20:229\u201339.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2804_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.","journal-title":"BMJ"},{"key":"2804_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jamainternmed.2024.0276","volume":"184","author":"C Crump","year":"2024","unstructured":"Crump C, Sundquist J, Sundquist K. Adverse pregnancy outcomes and long-term mortality in women. JAMA Intern Med. 2024;184:631\u201340.","journal-title":"JAMA Intern Med"},{"key":"2804_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00125-018-4575-5","volume":"61","author":"S Knorr","year":"2018","unstructured":"Knorr S, Juul S, Bytoft B, Lohse Z, Clausen TD, Jensen RB, et al. Impact of type 1 diabetes on maternal long-term risk of hospitalisation and mortality: a nationwide combined clinical and register-based cohort study (The EPICOM study). Diabetologia. 2018;61:1071\u201380.","journal-title":"Diabetologia"},{"key":"2804_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00125-006-0544-5","volume":"50","author":"D Gordin","year":"2007","unstructured":"Gordin D, Hiilesmaa V, Fagerudd J, Forsblom C, Kaaja R, Teramo K, et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia. 2007;50:516\u201322.","journal-title":"Diabetologia"},{"key":"2804_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00592-012-0415-0","volume":"50","author":"D Gordin","year":"2013","unstructured":"Gordin D, Kaaja R, Forsblom C, Hiilesmaa V, Teramo K, Groop P-H. Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life. Acta Diabetol. 2013;50:781\u20137.","journal-title":"Acta Diabetol"},{"key":"2804_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.diabet.2020.09.001","volume":"46","author":"B Verg\u00e8s","year":"2020","unstructured":"Verg\u00e8s B. Cardiovascular disease in type 1 diabetes: a review of epidemiological data and underlying mechanisms. Diabetes Metab. 2020;46:442\u20139.","journal-title":"Diabetes Metab"},{"key":"2804_CR18","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2337\/db08-1543","volume":"58","author":"P-H Groop","year":"2009","unstructured":"Groop P-H, Thomas MC, Moran JL, Wad\u00e8n J, Thorn LM, M\u00e4kinen V-P, et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58:1651\u20138.","journal-title":"Diabetes"},{"key":"2804_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ecl.2019.05.008","volume":"48","author":"DR McCance","year":"2019","unstructured":"McCance DR, Casey C. Type 1 diabetes in pregnancy. Endocrinol Metab Clin North Am. 2019;48:495\u2013509.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2804_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5694\/mja14.01691","volume":"203","author":"M Kyi","year":"2015","unstructured":"Kyi M, Wentworth JM, Nankervis AJ, Fourlanos S, Colman PG. Recent advances in type 1 diabetes. Med J Aust. 2015;203:290\u20133.","journal-title":"Med J Aust"},{"key":"2804_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MED.0000000000000599","volume":"28","author":"J Vliebergh","year":"2021","unstructured":"Vliebergh J, Lefever E, Mathieu C. Advances in newer basal and bolus insulins: impact on type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2021;28:1\u20137.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2804_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00125-022-05820-4","volume":"66","author":"G Desoye","year":"2023","unstructured":"Desoye G, Ringholm L, Damm P, Mathiesen ER, van Poppel MNM. Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason? Diabetologia. 2023;66:33\u201343.","journal-title":"Diabetologia"},{"key":"2804_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41574-019-0197-3","volume":"15","author":"L Ringholm","year":"2019","unstructured":"Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol. 2019;15:406\u201316.","journal-title":"Nat Rev Endocrinol"},{"key":"2804_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.diabet.2018.04.007","volume":"45","author":"J Lepercq","year":"2019","unstructured":"Lepercq J, Le Ray C, Godefroy C, Pelage L, Dubois-Laforgue D, Timsit J. Determinants of a good perinatal outcome in 588 pregnancies in women with type 1 diabetes. Diabetes Metab. 2019;45:191\u20136.","journal-title":"Diabetes Metab"},{"key":"2804_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","volume":"9","author":"HR Murphy","year":"2021","unstructured":"Murphy HR, Howgate C, O\u2019Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021;9:153\u201364.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2804_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S2213-8587(21)00172-8","volume":"9","author":"V Harjutsalo","year":"2021","unstructured":"Harjutsalo V, Pongrac Barlovic D, Groop P-H. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study. Lancet Diabetes Endocrinol. 2021;9:575\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2804_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","volume":"139","author":"S Grandi","year":"2019","unstructured":"Grandi S, Filion K, Yoon S, Ayele H, Doyle C, Hutcheon J, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139:1069\u201379.","journal-title":"Circulation"},{"key":"2804_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000508036","volume":"145","author":"R Wu","year":"2020","unstructured":"Wu R, Wang T, Gu R, Xing D, Ye C, Chen Y, et al. Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: a systematic review and meta-analysis. Cardiology. 2020;145:633\u201347.","journal-title":"Cardiology"},{"key":"2804_CR29","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1093\/ndt\/gfq275","volume":"25","author":"MK Sandvik","year":"2010","unstructured":"Sandvik MK, Iversen BM, Irgens LM, Skjaerven R, Leivestad T, S\u00f8fteland E, et al. Are adverse pregnancy outcomes risk factors for development of end-stage renal disease in women with diabetes? Nephrol Dial Transplant. 2010;25:3600\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"2804_CR30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(00)02800-2","volume":"Oct 7;356(9237)","author":"JJ Walker","year":"2000","unstructured":"Walker JJ. Pre-eclampsia. Lancet. 2000;356:1260-5. PMID: 11072961","journal-title":"Lancet"},{"key":"2804_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","volume":"25","author":"JA Hutcheon","year":"2011","unstructured":"Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391\u2013403.","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02804-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02804-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02804-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:02:35Z","timestamp":1749931355000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02804-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2804"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02804-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.J.S. has received lecture fees from AstraZeneca and Boehringer Ingelheim. P.-H.G. has received investigator-initiated research grants from Eli Lilly and Roche, is an advisory board member for AbbVie, Astellas, AstraZeneca, Boehringer Ingelheim, Cebix, Eli Lilly, Janssen, Medscape, Merck Sharp & Dohme, Mundipharma, Nestle, Novartis, Novo Nordisk and Sanofi; and has received lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Merck Sharp & Dohme, Medscape, Novartis, Novo Nordisk, PeerVoice, and Sanofi. D.G. Lecture or Advisory Board Honoraria: Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, GE Healthcare, Harald AI, Novo Nordisk, Ratiopharm.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}